The WISDOM self-management intervention: A cost-effectiveness analysis to support the transformation of type 2 diabetes care in England

Objectives To assess the cost-effectiveness of the WISDOM self-management intervention for type 2 diabetes compared with care as usual. Design We performed a difference-in-differences analysis to estimate differences in risk factors for diabetes complications between people in the WISDOM group (n = 25, 276) and a control group (n = 15, 272) using GP records. A decision analytic model was then used to extrapolate differences in risk factors into costs and outcomes in the long term. Setting Participating GP practices in West Hampshire and Southampton, UK. Participants All people diagnosed with type 2 diabetes between January 1990 and March 2020 (n = 40,548). Outcomes Diabetes-related complications, quality-adjusted life years (QALYs) and costs to the English National Health Service at 5 years and lifetime. Interventions The WISDOM intervention included risk stratification, self-management education programme to professionals and people with type 2 diabetes, and monitoring of key treatment targets. Results WISDOM was associated with less atrial fibrillation [p = 0.001], albuminuria [p = 0.002] and blood pressure [p = 0.098]. Among all people in the intervention group, WISDOM led to 51 [95%CI: 25; 76] QALYs gained and saved 278,036 pound [95%CI: -631,900; 176,392] in the first 5 years after its implementation compared with care as usual. During those people' lifetime, WISDOM led to 253 [95%CI: 75; 404] QALYs gained and cost saving of 126,380 pound [95%CI: -1,466,008; 1,339,628]. The gains in QALYs were a result of reduced diabetes-related complications through improved management of the associated risk factors. Conclusions The WISDOM risk-stratification and education intervention for type 2 diabetes appear to be cost-effective compared to usual care by reducing diabetes complications.

Automated summary

The WISDOM self-management intervention for type 2 diabetes appears to be cost-effective compared to usual care by reducing diabetes complications. It leads to increased quality-adjusted life years (QALYs) and cost savings through improved management of risk factors.